MedPath

Fatigue After STroke Educational Recovery trial (FASTER)

Not Applicable
Completed
Conditions
post-stroke fatigue
Stroke - Haemorrhagic
Stroke - Ischaemic
Registration Number
ACTRN12619000626167
Lead Sponsor
Auckland University of Technology
Brief Summary

Results are not yet available.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
200
Inclusion Criteria

To be eligible to take part in the study, potential participants must meet the following criteria:
(a) CT/MRI confirmed stroke to enable exclusion of stroke-mimic conditions;
(b) clinically significant fatigue at 3 to 24-months after stroke;
(c) residing in the study areas (Auckland, Waikato) to ensure feasibility;
(d) ability to converse in English to support understanding of group discussions and materials; and
(e) able to provide informed consent.

Exclusion Criteria

Pre-stroke fatigue, given differing aetiology requiring a different intervention approach; significant cognitive (MMSE <23 or Montreal Cognitive Assessment <26) or behavioural impairments (e.g. agitation, major depressive criteria measured by the CES-D revised - depression scale); significant disability (mRS 4-5) due to high dependence for basic Acitivities of Daily Living making some Fatigue Severity Scale (FSS) items not applicable (i.e. ‘my fatigue prevents sustained physical functioning) making it difficult to accurately detect changes in fatigue; identified causes of chronic fatigue (e.g. sleep apnea); medical instability, or other health condition (e.g. dementia, drug/alcohol abuse) that would preclude full participation; and participation in another clinical trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Aim 1 (Primary objective) - to assess the effectiveness of the FMG intervention on subjective experiences of PSF severity immediately after the intervention (6-weeks) compared to a UC usual care group using Fatigue Severity Scale - 9. [Immediately after the intervention (6-weeks)];to assess the effectiveness of the FMG intervention on subjective experiences of PSF dimensionality immediately after the intervention (6-weeks) compared to a Usual Care (UC) group using the Multidimensional Fatigue Inventory - 20.[immediately after the intervention (6-weeks)]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath